APA

Blecher G. E., Stiell I. G., Rowe B. H., Lang E., Brison R. J., Perry J. J., Clement C. M., Borgundvaag B., Langhan T., Magee K., Stenstrom R., Birnie D. & Wells G. A. (20121106). Use of rate control medication before cardioversion of recent-onset atrial fibrillation or flutter in the emergency department is associated with reduced success rates. : CJEM.

Chicago

Blecher Gabriel E, Stiell Ian G, Rowe Brian H, Lang Eddy, Brison Robert J, Perry Jeffrey J, Clement Catherine M, Borgundvaag Bjug, Langhan Trevor, Magee Kirk, Stenstrom Rob, Birnie David and Wells George A. 20121106. Use of rate control medication before cardioversion of recent-onset atrial fibrillation or flutter in the emergency department is associated with reduced success rates. : CJEM.

Harvard

Blecher G. E., Stiell I. G., Rowe B. H., Lang E., Brison R. J., Perry J. J., Clement C. M., Borgundvaag B., Langhan T., Magee K., Stenstrom R., Birnie D. and Wells G. A. (20121106). Use of rate control medication before cardioversion of recent-onset atrial fibrillation or flutter in the emergency department is associated with reduced success rates. : CJEM.

MLA

Blecher Gabriel E, Stiell Ian G, Rowe Brian H, Lang Eddy, Brison Robert J, Perry Jeffrey J, Clement Catherine M, Borgundvaag Bjug, Langhan Trevor, Magee Kirk, Stenstrom Rob, Birnie David and Wells George A. Use of rate control medication before cardioversion of recent-onset atrial fibrillation or flutter in the emergency department is associated with reduced success rates. : CJEM. 20121106.